Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover

Genmab A/S rose the most in a week in Copenhagen trading after Nordea Bank AB said an experimental cancer treatment that the Danish company is developing with Johnson & Johnson will boost the share price.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.